SRF Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹4,904 Cr +34.7% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
S

SRF Ltd

Q4 FY26Chemicals & Petrochemicals

SRF Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹4,615Cr
+7% YoY
+24.3% QoQ
Net profit
₹582Cr
+10.6% YoY
+34.4% QoQ
Margin
22%
0 pp YoY
+1 pp QoQ
Price₹2,550
Market cap₹74.5K Cr
P/E33.2

The short version

Chemicals business expected to grow 15% to 20% in FY27 despite pricing pressures and volatility. Chemicals business expected to grow 15%-20% in FY27 driven by strong product pipeline, technological interventions, and ramp-up of fluoropolymers and HFO capacities.

From SRF Ltd's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

  • Chemicals business expected to grow 15% to 20% in FY27 despite pricing pressures and volatility.
  • Strong product pipeline critical, spanning from intermediates through to AI and specialty chemicals.
  • Fluoropolymer segment ramp-up anticipated in latter half of current year, with good revenue ramp expected in FY27.
  • Chemours arrangement starting post-December FY26 (Q4), expected to yield high-margin outcomes.
  • Exports of aluminum foil have commenced, with further growth expected through 2027.
  • Incremental capacity enhancements underway at HFC segment, targeting over 65,000 MT per annum post-debottlenecking.
  • New HFO portfolio capacity of 20,000 MT planned at Odisha site, with commissioning expected by February 2028.

2 more points from SRF Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what SRF Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • INR2,300 crore investment at Odisha over next 2 years for fourth-generation refrigerant gases capacity (20,000 MT/year) plus backward integration into hydrofluoric acid (30,000 MT), including electronic grade HF.
  • Planned capex of approximately INR2,500 crore for FY27 aligned with long-term growth priorities.
  • Successful start-up of capacitor-grade BOPP films plant (KAPLAR); to be capitalized shortly.
  • BOPP & BOPE line expected to commence production in July FY27.
  • Investment of INR180 crore in state-of-the-art BOPA (polyamide) line, expected operational by September 2027 (India’s first with simultaneous stretching).
  • Pharma intermediates plant number 2 is coming up; on track at Dahej.
  • Ongoing debottlenecking in chemicals to increase capacity north of 65,000 MT/year.

2 more points from SRF Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what SRF Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • It was mentioned that the company has very strong demand pull currently, meaning robust order inflows.
  • There is ongoing fulfillment of demand, including exports, with no significant inventory stocking noted.
  • The fluoropolymer segment and aluminum exports are ramping up, with good customer interest and approvals in progress.
  • Upcoming projects, like the Chemours arrangement, are expected to contribute positively to order execution from Q4 FY26 and into FY27.

2 more points from SRF Ltd's call on order book

Create a free account to keep reading this call

SRF Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

SRF Ltd Q4 FY26 results — key figures

SRF Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue4,6154,313+7%3,713+24.3%
Operating profit (EBITDA)1,026957+7.2%780+31.5%
Operating margin22%22%0 pp21%+1 pp
Profit before tax757707+7.1%452+67.5%
Net profit (PAT)582526+10.6%433+34.4%
EPS (₹)19.6317.75+10.6%14.60+34.5%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹4.9K Cr, net profit ₹509 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

SRF Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were SRF Ltd Q4 FY26 results?

Chemicals business expected to grow 15% to 20% in FY27 despite pricing pressures and volatility. Chemicals business expected to grow 15%-20% in FY27 driven by strong product pipeline, technological interventions, and ramp-up of fluoropolymers and HFO capacities.

What is SRF Ltd share price analysis?

SRF Ltd currently shows a neutral. The stock trades at a P/E of 33.2 with a market cap of ₹74,462 Cr. Investors should review the full earnings analysis for detailed insights.

Is SRF Ltd planning capital expenditure?

INR2,300 crore investment at Odisha over next 2 years for fourth-generation refrigerant gases capacity (20,000 MT/year) plus backward integration into hydrofluoric acid (30,000 MT), including electronic grade HF.

Keep SRF Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.